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Summary
In searching for binding partners of the intracellular
domain of the immunoglobulin superfamily adhesion
molecule CHL1, we identified the clathrin-uncoating
ATPase Hsc70. CHL1 gene ablation resulted in re-
duced targeting of Hsc70 to the synaptic plasma mem-
brane and synaptic vesicles, suggesting CHL1 as a
synapse-targeting cue for Hsc70. CHL1 accumulates
in presynaptic membranes and, in response to syn-
apse activation, is targeted to synaptic vesicles by en-
docytosis. CHL1 deficiency or disruption of the CHL1/
Hsc70 complex results in accumulation of abnormally
high levels of clathrin-coated synaptic vesicles with a
reduced ability to release clathrin. Generation of new
clathrin-coated synaptic vesicles in an activity-depen-
dent manner is inhibited when the CHL1/Hsc70 com-
plex is disrupted, resulting in impaired uptake and
release of FM dyes in synaptic boutons. Abnormalities
in clathrin-dependent synaptic vesicle recycling may
thus underlie brain malfunctions in humans and mice
that carry mutations in the CHL1 gene.
Introduction
The close homolog of L1 (CHL1, also referred to as
CALL) is a cell adhesion molecule of the immunoglobulin
(Ig) superfamily. In the developing brain, CHL1 regulates
neuronal migration (Buhusi et al., 2003) and neurite out-
growth (Hillenbrand et al., 1999). Mice deficient in CHL1
show reduced migration and positioning of pyramidal
cells and elaboration of dendrites in the caudal, but
not in the rostral, part of the cerebral cortex (Demya-
nenko et al., 2004). Mapping to chromosome h3p26.1
in humans, the CHL1 gene, may be associated with intel-
ligence (Angeloni et al., 1999a). Loss or mutations of
CHL1 may contribute to mental impairment associated
with ‘‘3p-syndrome’’ (Angeloni et al., 1999b) and mental
retardation (Frints et al., 2003). Ablation of the CHL1
gene in mice alters their exploratory behavior in a novel
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Torrey Pines Road, La Jolla, California 92037.environment and reduces emotional reactivity and motor
coordination (Montag-Sallaz et al., 2002; Pratte et al.,
2003); CHL1 deficiency in mice leads to reduced pre-
pulse inhibition of the acoustic startle response, a mea-
sure of the ability of the central nervous system to gate
the flow of sensorimotor information (Irintchev et al.,
2004). Mutations in CHL1 in humans correlate with the
occurrence of schizophrenia (Sakurai et al., 2002; Chen
et al., 2005), a neuropsychiatric disorder associated
with abnormal neurocircuits and functioning of synapses
(Harrison and Weinberger, 2005). Although these find-
ings suggest that CHL1 regulates synapse functioning,
the role of CHL1 in the organization of the synaptic
machinery has not been fully analyzed.
The 70 kDa heat shock cognate protein (Hsc70) is a
constitutively expressed member of the heat shock-
inducible Hsp70 protein family. These proteins possess
ATPase activity and perform numerous functions in
cells, among which are protein folding and sorting, sig-
nal transduction, and apoptosis. Hsc70 also catalyzes,
in vitro and in vivo, the release of clathrin from clathrin-
coated vesicles as the final step of receptor-mediated
endocytosis (Newmyer and Schmid, 2001). A similar
function is attributed to Hsc70 in synapses, where
Hsc70 regulates uncoating of synaptic vesicles (SVs) in
the clathrin-dependent recycling pathway (Zinsmaier
and Bronk, 2001). In this pathway, following SV fusion,
the SV membrane is endocytosed via formation of
clathrin-coated pits on the synaptic plasma membrane,
resulting in formation of clathrin-coated synaptic vesi-
cles (CCSVs) (Takei et al., 1996; Shupliakov et al., 1997).
During CCSV uncoating, Hsc70 co-operates with other
proteins that target or regulate the activity of Hsc70, such
as auxilin, which binds to Hsc70 in the presence of ATP
and increases the activity of Hsc70 in CCSV uncoating
(Morgan et al., 2001). In the present study, we show
that Hsc70 binds to the intracellular domain of CHL1
and that this interaction is potentiated by ADP. CHL1 ac-
cumulates in the presynaptic plasma membrane, and
there it recruits Hsc70 in an ADP-dependent manner. In
response to synapse activation, CHL1 is targeted to
SVs by endocytosis. CHL1 deficiency causes a reduction
in levels of Hsc70 on SVs and leads to reduced clathrin
release from CCSVs and reduced uptake and release
of FM dyes in synaptic boutons. These observations
suggest a role for CHL1 in regulating SV recycling via a
clathrin-dependent pathway.
Results
Hsc70 Binds to the Intracellular Domain of CHL1
To identify binding partners of the CHL1 intracellular
domain (CHL1-ID), soluble protein fraction from adult
mouse brain was used for two-dimensional (2D) gel
electrophoresis, after which proteins were either trans-
ferred to nitrocellulose membrane or subjected to silver
staining. Blotted membranes were then incubated with
recombinant CHL1-ID, and binding of CHL1-ID to pro-
teins immobilized in the nitrocellulose membrane was
analyzed. The most prominent binding was observed
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1012Figure 1. CHL1-ID Directly Interacts with
Hsc70 via Its HPD Tripeptide
(A) A soluble fraction from adult mouse brain
homogenate was separated by two-dimen-
sional (2D) gel electrophoresis. Proteins
were then transferred to nitrocellulose and
subjected to an overlay assay with CHL1-ID.
Alternatively, gels were silver stained. Note
that CHL1-ID bound most prominently to a
70 kDa spot with the slightly acidic isoelectric
point of 5.5. The dark gray arrow on the silver-
stained gel shows the corresponding 70 kDa
spot isolated and used for MALDI-MS analy-
sis, which showed it to contain Hsc70. Strip-
ped after the overlay, membranes were re-
probed with antibodies against Hsc70 or
Hsp70. Note that Hsc70 antibodies detected
a spot overlapping with the area containing
the binding partner of CHL1-ID. Antibodies
against Hsp70 labeled a 70 kDa spot with
the more basic 5.8 isoelectric point.
(B) CHL1 was immunoprecipitated (IP) from
lysates of brain homogenates. Immunopre-
cipitates, protein input, and material not
bound to the beads were probed with anti-
bodies against CHL1 and Hsc70 by western
blot (WB). Hsc70 was coimmunoprecipitated
with CHL1. Immunoprecipitation with non-
specific immunoglobulins (IgG) was per-
formed for control.
(C) Amino acid sequences of the IDs of human
and mouse CHL1 and mouse L1 are shown.
The HPD tripeptide is marked in dark gray in
the IDs of human and mouse CHL1. Overlap-
ping sequences are given in gray.
(D) CHO cells were transfected with full-
length, wild-type mouse CHL1 (WT) or CHL1
containing the indicated mutations in the
HPD tripeptide. The three CHL1 constructs
and endogenous Hsc70 were expressed at
similar levels in the cell lysates. Wild-type
CHL1 and CHL1 mutants were IP from cell
lysates. Hsc70 coimmunoprecipitated only
with wild-type CHL1.
(E) Brain lysates were preincubated with the
HPD tripeptide-containing peptide VKEKED
LHPDPEVQSAKDET derived from CHL1-ID
(HPD), or with a similar peptide VKEKEDLQPDPEVQSAKDET containing a point mutation in the HPD tripeptide (QPD). Whereas similar levels
of CHL1 were IP, coimmunoprecipitation of Hsc70 was inhibited in lysates preincubated with the HPD tripeptide-containing peptide. Immunopre-
cipitation with nonspecific IgG was performed for control.in the 70 kDa area at a slightly acidic isoelectric point of
approximately 5.5 (Figure 1A). The corresponding spot
in silver-stained gels was isolated and subjected to
matrix-assisted laser desorption/ionization mass spec-
trometry (MALDI-MS) analysis, which identified heat
shock cognate Hsc70. To confirm this finding, nitrocellu-
lose membranes used for the overlay experiments were
stripped and reprobed with antibodies against Hsc70,
which indeed bound to the area overlapping with the
spot containing the binding partner of CHL1-ID (Fig-
ure 1A). For comparison, antibodies against Hsp70
were used, which revealed a 70 kDa spot with the more
basic isoelectric point of 5.8.
To analyze whether CHL1 associates with Hsc70 in
brain tissue of adult mice, CHL1 was immunoprecipi-
tated from brain lysates and immunoprecipitates were
probed with antibodies against Hsc70. Approximately
20% of all Hsc70 coimmunoprecipitated with CHL1,
suggesting that the observed interaction is physiologi-
cally relevant (Figure 1B).Hsc70 Binds to the HPD Tripeptide in the Intracellular
Domain of CHL1
Analysis of the CHL1-ID amino acid sequence revealed
an HPD tripeptide that had been identified in other pro-
teins as a binding site for Hsp70 proteins (Figure 1C).
This conserved HPD motif is present in the J domains
of DnaJ-like proteins, which are co-chaperones of
Hsp70 proteins that bind to Hsp70 proteins to induce
their ATPase activity. A single mutation of any amino
acid in the HPD tripeptide blocks the interaction between
DnaJ and Hsp70 proteins, indicating that the HPD motif
is crucial for this interaction (Tsai and Douglas, 1996;
Chamberlain and Burgoyne, 1997). Both mouse and
human CHL1 sequences contain the HPD tripeptide,
whereas it is not present in the intracellular domain of
L1. To analyze the role of the HPD tripeptide in CHL1/
Hsc70 complex formation, wild-type full-length CHL1,
or full-length variants of CHL1 with the single amino
acid mutation within the HPD tripeptide CHL1H1121Q
(histidine exchanged to glutamine) or CHL1D1123A
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1013Figure 2. CHL1 Accumulates at the Presyn-
aptic Membrane
(A) Brain homogenates (hom.), synapto-
somes (syn.), crude SVs (SVs), and synaptic
plasma membranes (PM) were probed by
WB with antibodies against CHL1, Na,K-
ATPase as a marker of plasma membranes,
synaptophysin as a marker of SVs, and
Hsc70. The diagram shows quantitation of
CHL1 labeling from six experiments, with
the optical density in the western blot of the
homogenate set to 100%. Mean values 6
SEM are shown. CHL1 is enriched in the syn-
aptic plasma membrane and is present in
SVs. (B–D) Hippocampal neurons were im-
munolabeled for cell surface, exposed CHL1
and colabeled for Hsc70 and SV2 (B), synap-
tophysin and PSD95 (C), GAD65 (D), or ge-
phyrin (E). CHL1 accumulates at sites of SV2
positive synaptic boutons containing Hsc70
(B, arrows). CHL1-positive synaptic boutons
marked by synaptophysin are apposed to
clusters of PSD95 (C, arrows) and gephyrin
(E, arrows). CHL1-positive synaptic boutons
are either positive (D, arrows) or negative
(D, arrowheads) for GAD65. In (C), a higher
magnification of the region marked with the
dashed square is shown on the right. Bars =
10 mm (B), 5 mm (C–E), 1 mm (C, higher magni-
fication).(aspartic acid exchanged to alanine), were transfected
into Chinese hamster ovary (CHO) cells and assayed by
coimmunoprecipitation for their ability to associate
with endogenously expressed Hsc70. Whereas Hsc70
coimmunoprecipitated with wild-type CHL1, it did not
coimmunoprecipitate with any CHL1 variant mutated in
the HPD tripeptide (Figure 1D), indicating that the HPD
tripeptide is essential for the binding of Hsc70 to CHL1.
Furthermore, when brain lysates were incubated with
an HPD tripeptide-containing 20-mer peptide derived
from the CHL1-ID sequence (HPDpeptideCHL1) and sub-
sequently subjected to immunoprecipitation with CHL1
antibodies, Hsc70 did not coimmunoprecipitate (Fig-
ure 1E), indicating that the HPD tripeptide-containing
peptide competed with endogenous CHL1 for binding
to Hsc70. By contrast, preincubation with a similar pep-
tide in which the histidine was exchanged to glutamine
within the HPD tripeptide (QPDpeptideCHL1) did not af-
fect the complex formation between CHL1 and Hsc70.
Thus, the HPD tripeptide is essential for CHL1/Hsc70
complex formation in brain tissue.
CHL1 Is Accumulated in the Presynaptic
Plasma Membrane
To investigate the possibility that CHL1 is involved in the
regulation of synapse functions, we analyzed the subcel-
lular distribution of CHL1 (Figure 2A). CHL1 was enriched
in synaptosomes; the level of CHL1 was approximately
six times higher in synaptosomes when compared with
brain homogenates. At the subsynaptic level, CHL1
was particularly enriched in the synaptic plasma mem-brane. Unexpectedly, we also detected CHL1 in the
crude SV fraction. In both the synaptic plasma mem-
brane and SV fractions, CHL1 cofractionated with Hsc70.
In cultured hippocampal neurons labeled with anti-
bodies against CHL1 without permeabilization of the
plasma membrane with detergent, CHL1 immunolabel-
ing was localized to thin neurites negative for the den-
dritic marker MAP2 and positive for the axonal marker
L1 (see Figure S1A in the Supplemental Data), indicating
that CHL1 is enriched in the axonal plasma membrane.
After permeabilization of neurons with detergent, intra-
cellular CHL1 was also detected in the somata of neu-
rons and, to a lesser extent, in their dendrites (Fig-
ure S1B). In accordance with the biochemical data,
plasma membrane-associated CHL1 was highly ex-
pressed in presynaptic terminals visualized with anti-
bodies against the SV protein SV2. In presynaptic termi-
nals, CHL1 colocalized with Hsc70 (Figure 2B). CHL1
was detectable in both excitatory and inhibitory synap-
ses, as indicated by apposition of CHL1 accumulations
to the clusters of postsynaptic proteins of excitatory
and inhibitory synapses (PSD95 and gephyrin, respec-
tively), and by accumulation of CHL1 in synaptic bou-
tons either positive or negative for GAD65, a presynaptic
marker of inhibitory synapses (Figures 2C–2E).
CHL1 Recruits Hsc70 to Synapses
Cell adhesion molecules accumulated in synapses have
been shown to anchor associated proteins at these sites
(Sytnyk et al., 2004; Gerrow and El-Husseini, 2006). To
analyze levels of Hsc70 in presynaptic boutons, we
Neuron
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(A) Neurons from CHL1+/+ and CHL12/2 mice were colabeled with antibodies against synaptophysin (synapt.) and Hsc70. Immunofluorescence
signals were inverted to accentuate differences in immunolabeling intensities between genotypes. Diagrams show mean intensity 6 SEM of
Hsc70 and synaptophysin labeling in synaptophysin clusters. AU, arbitrary units. Levels of Hsc70 are reduced in CHL12/2 versus CHL1+/+ syn-
aptic boutons (arrows). Bar = 10 mm. n > 200 synapses from images of 20 neurites from two coverslips analyzed in each group. *p < 0.05, t test.
(B) Synaptosomes and brain homogenates from CHL1+/+ and CHL12/2 mice were probed by WB with antibodies against Hsc70 and synapto-
physin or actin. Diagrams show quantitation of the blots from six experiments. Optical density in wild-type was set to 100%. Mean values 6
SEM are shown. *p < 0.05, paired t test. Levels of Hsc70 are reduced, whereas levels of synaptophysin are not changed in CHL12/2 versus
CHL1+/+ synaptosomes. Levels of Hsc70 are increased, whereas levels of actin are not changed, in CHL12/2 brain homogenates.
(C)CHL12/2 neurons cotransfected with Hsc70GFP and the empty vector (pcDNA3) or vector containing full-length, wild-type CHL1 (CHL1WT) or
CHL1H1121Q were colabeled with antibodies against SV2 and surface CHL1. Hsc70GFP, CHL1WT, and CHL1H1121Q accumulate in SV2 pos-
itive synaptic boutons (arrows). Inverted immunofluorescence signals are shown. Note increased extrasynaptic levels of Hsc70GFP in CHL12/2
neurons cotransfected with pcDNA3 or CHL1H1121Q (arrowheads). Bar = 10 mm. Diagrams show mean values 6 SEM of the ratio of Hsc70GFP
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with Hsc70 antibody. Neurons were colabeled with syn-
aptophysin antibody to identify presynaptic boutons,
which were then graphically outlined to determine
Hsc70 levels within the synaptophysin accumulations.
Indeed, Hsc70 levels in synaptophysin accumulations
were reduced in neurons derived from CHL1-deficient
(CHL12/2) mice (Figure 3A). Hsc70 levels were also re-
duced in synaptosomes isolated from CHL12/2 brains
(Figure 3B), indicating that CHL1 is involved in targeting
of Hsc70 to synapses. Interestingly, Hsc70 mRNA and
protein levels were slightly increased in CHL12/2 brain
homogenates (Figure 3B and Figure S3), probably re-
flecting a compensatory reaction to inefficient targeting
of the protein to synapses. This observation excludes
the possibility that reduced levels of Hsc70 in synapto-
somes reflect an overall decreased expression of
Hsc70 in CHL12/2 brains. Levels of the SV protein syn-
aptophysin were the same in presynaptic boutons of
cultured neurons and synaptosomes from both wild-
type (CHL1+/+) and CHL12/2 mice (Figures 3A and 3B),
showing that overall targeting of SVs was not affected
in CHL12/2 brains.
To analyze the effect of CHL1 on the subcellular local-
ization of Hsc70 in detail, we cotransfected cultured
CHL12/2 neurons with wild-type CHL1 or the tripeptide
mutation CHL1H1121Q together with Hsc70 tagged
with green fluorescent protein (Hsc70GFP). Transfected
full-length CHL1 showed a distribution similar to endog-
enous CHL1 expressed by CHL1+/+ neurons; it was en-
riched in axons and SV2 antibody-labeled synaptic bou-
tons (Figure 3C). InCHL12/2 neurons cotransfected with
Hsc70GFP and the empty pcDNA3 vector, Hsc70GFP
was still targeted to SV2 positive synaptic boutons.
This finding indicates that cues other than CHL1 can re-
cruit Hsc70 to synapses. Interestingly, levels of CSP, an
SV-associated protein that directly binds to Hsc70, were
2-fold higher inCHL12/2 brain homogenates and synap-
tosomes (Figure S2), correlating with increased mRNA
levels of CSP in CHL12/2 brains (Figure S3). Thus,
Hsc70 may be recruited to CHL12/2 synapses by CSP.
However, cotransfection with wild-type full-length
CHL1 significantly enhanced the precision and degree
of Hsc70GFP accumulation in synapses as determined
by the ratio of Hsc70GFP levels in the center of SV2 clus-
ters to the Hsc70 levels in the axon 3 mm away from the
cluster center (Hsc70syn./Hsc70adj.). This ratio was two
times higher in CHL1 cotransfected neurons (Figure 3C).
In contrast to transfection with CHL1, transfection with
the CHL1H1121Q mutant did not enhance targeting of
Hsc70GFP to SV2 positive synaptic boutons, showing
that the interaction between the HPD tripeptide of
CHL1 and Hsc70 plays a crucial role in CHL1-mediated
recruitment of Hsc70 to synapses.
CHL1 Regulates Recruitment of Hsc70 to Synaptic
Plasma Membranes and SVs
Interestingly, Hsc70 and CHL1 were present in both the
synaptic plasma membrane and the SV fractions(Figure 2A), raising the possibility that CHL1 recruits
Hsc70 to these subsynaptic compartments. Since inter-
actions of Hsc70 with its binding partners are often reg-
ulated by nucleotides, changes in ATP/ADP concentra-
tion may provide an additional level of regulation. Thus,
we tested whether ATP or ADP influence CHL1/Hsc70
complex formation. Amounts of Hsc70 that coimmuno-
precipitated with CHL1 from brain lysates were approx-
imately 4-fold higher in the presence of ADP than in the
absence of nucleotides (Figure 4A), indicating that com-
plex formation is enhanced by ADP. Interestingly, ATP
reduced the efficiency of CHL1/Hsc70 complex forma-
tion to the level below the level observed in the absence
of nucleotides.
To analyze the role of CHL1 and nucleotides in the
recruitment of Hsc70 to the plasma membrane, synaptic
plasma membrane fractions were isolated from synapto-
somes of CHL1+/+ and CHL12/2 brains. These fractions
were then assayed for their ability to recruit Hsc70 from
the soluble fraction of CHL1+/+ brain homogenates
used as a source of endogenous Hsc70 (Figure 4B). Be-
fore incubation with the soluble fraction, peripheral pro-
teins in the isolated synaptic membranes were stripped
by alkaline treatment to remove Hsc70 that may have
been copurified. Incubation with the soluble fraction re-
sulted in the binding of Hsc70 to CHL1+/+, but not to
CHL12/2, synaptic plasma membranes, indicating that
CHL1 is required to recruit Hsc70 to synaptic plasma
membranes. Efficiency of the binding was approximately
three times higher in the presence of ADP when com-
pared with the binding process without nucleotides,
whereas addition of ATP abolished the binding.
To analyze the role of CHL1 in SVs, SVs were purified
by fractionation of the crude SV fractions from CHL1+/+
and CHL12/2 brains through a linear sucrose gradient
followed by SV immunoisolation with the synaptophysin
antibodies (Figure 4C). Purified SVs were strongly en-
riched in synaptophysin and were negative for the
marker of the plasma membrane Na,K-ATPase and the
early endosome associated protein EEA1 (not shown).
Purified SVs from CHL1+/+ brains contained CHL1, as
revealed by immunoblot analysis (Figure 4C). Levels of
Hsc70 were significantly decreased in CHL12/2 SVs
compared with CHL1+/+ SVs (Figure 4C), indicating
that CHL1 recruits Hsc70 to SVs.
CHL1 Is Endocytosed to Synapses in Response
to Synapse Activation
As a next step we tried to investigate the mechanisms
that target CHL1 to SVs. As a transmembrane protein,
CHL1 can be delivered to synapses in trans-Golgi net-
work-derived organelles, which are then transformed
to SVs (Hannah et al., 1999; Sytnyk et al., 2002; Zhai
et al., 2001; Ahmari et al., 2000). However, considering
the high levels of CHL1 in the synaptic plasma mem-
brane (Figure 2A), a more potent pathway for CHL1 ac-
cumulation in SVs could be its endocytosis during SV
recycling. To test the latter possibility, we analyzed the
sites of CHL1 endocytosis and recycling in culturedlevels in the center of the SV2 cluster to Hsc70 levels in the adjacent axon 3 mm away from the SV2 cluster center. Cotransfection with CHL1WT
enhances recruitment of Hsc70GFP to SV2 clusters, resulting in higher Hsc70syn./Hsc70adj. values. n > 100 synapses from ten neurons from two
to three coverslips analyzed in each group. Asterisk shows a statistically significant difference when compared with pcDNA3 cotransfected
neurons (p < 0.05, t test).
Neuron
1016Figure 4. CHL1 Recruits Hsc70 to the Synaptic Plasma Membrane and SVs and Is Endocytosed to Synaptic Boutons in an Activity-Dependent
Manner
(A) Brain lysates were preincubated with 1 mM ADP or 1 mM ATP. Similar levels of CHL1 were then IP from ADP- or ATP-treated or nontreated
lysates. Immunoprecipitates were then analyzed with antibodies against Hsc70 and clathrin by WB. The diagrams show quantitation of Hsc70
and clathrin labeling with optical density for nontreated lysates set to 100%. Asterisks show statistically significant differences when compared
with nontreated lysates. The highest amounts of Hsc70 and clathrin coimmunoprecipitate with CHL1 from lysates preincubated with ADP,
whereas ATP reduces CHL1/Hsc70 and CHL1/clathrin coimmunoprecipitation when compared with coimmunoprecipitation in the absence of
nucleotides. Immunoprecipitation with nonspecific IgG was performed for control. Diagrams show quantitation of the blots from six experi-
ments; mean values 6 SEM are shown; *p < 0.05, paired t test.
(B) Synaptic plasma membranes from CHL1+/+ or CHL12/2 brains were preincubated with the soluble fraction of brain homogenates (cytosol)
from CHL1+/+ brains in the presence or absence of 1 mM ADP or 1 mM ATP. Amounts of Hsc70 derived from the soluble fraction that had bound
to the membranes were then estimated by WB. Labeling with L1 antibodies shows that similar amounts of isolated synaptic plasma membranes
were used in each group. The diagram shows quantitation of Hsc70 labeling with optical density for nontreated CHL1+/+ synaptic membranes set
to 100%. Hsc70 binds only to CHL1+/+ membranes, with highest efficiency of binding in the presence of ADP. Diagrams show quantitation of the
blots from six experiments; mean values 6 SEM are shown; *p < 0.05, paired t test.
(C) CHL1+/+ and CHL12/2 SVs IP with antibodies against synaptophysin (IP: synapt.) were probed by WB with antibodies against CHL1, synap-
tophysin, and Hsc70. Note that CHL1+/+ SVs contain CHL1. Brain homogenate (BH) is shown for comparison. Diagram shows quantitation of
Hsc70 levels with the optical density in CHL1+/+ set to 100%. Hsc70 levels are reduced in CHL12/2 SVs. Immunoprecipitation with nonspecific
IgG was performed for control. Diagrams show quantitation of the blots from six experiments; mean values6 SEM are shown; *p < 0.05, paired
t test.
(D) Live neurons were incubated with antibodies against CHL1 and allowed to internalize the antibodies in the presence of nominal (4 mM) or high
(47 mM) K+. Immunolabeling of surface bound antibodies (surface CHL1) in neurons fixed without stripping shows that the antibodies bound to
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uptake of cell surface bound CHL1 antibodies to intra-
cellular organelles (Carroll et al., 1999). CHL1 antibodies
were applied to live cultured neurons in culture medium,
and neurons were then allowed to incorporate CHL1 an-
tibodies either at resting conditions in the presence of
nominal 4 mM K+ or in the presence of 47 mM K+ applied
to stimulate exo- and endocytosis of SVs by depolariz-
ing neuronal plasma membranes and inducing Ca2+
influx (Virmani et al., 2003). Antibodies bound to CHL1
at the cell surface were then removed by exposure to
0.5 M NaCl/0.2 M acetic acid, a procedure that did not re-
sult in abnormal swelling or degeneration of cells (not
shown). Following permeabilization of neurons with de-
tergent, internalized CHL1/CHL1 antibody complexes,
resistant to acid stripping, were detected with fluores-
cence-labeled secondary antibodies (Figure 4D; Carroll
et al., 1999). Colabeling with SV2 antibodies showed
that the major sites of CHL1 antibody uptake colocalized
with SV2 accumulations (Figure 4D). CHL1 was endocy-
tosed to synaptic boutons even at resting conditions,
probably due to antibody induced cross-linking of
CHL1 at the cell surface, followed by internalization and/
or basal synaptic activity in cultures. However, stimula-
tion with high K+ enhanced CHL1 endocytosis to synap-
tic boutons: levels of CHL1 antibody internalized to SV2
positive synaptic boutons of neurons stimulated by high
K+ were approximately two times higher than those of
nonstimulated neurons (Figure 4D).
To analyze the mechanisms by which CHL1 is endocy-
tosed in synaptic boutons, we investigated whether
CHL1 is present in CCSVs representing structural inter-
mediates in the clathrin-dependent SV recycling path-
way. Immunoblot analysis of the CCSVs isolated from
brain tissue (Maycox et al., 1992) showed that CCSVs
contained CHL1 (Figure 4E). Clathrin coimmunoprecipi-
tated with CHL1 from brain lysates, and the CHL1/cla-
thrin complex formation was potentiated by ADP and
inhibited by ATP in a manner similar to the regulation
of the CHL1/Hsc70 complex (Figure 4A). Endocytosed
CHL1 immunoreactive structures often appeared aside
the major synaptic vesicle cluster labeled with anti-
bodies against SV2 (Figure 4D), as has been reported
before for CCSVs (Bloom et al., 2003). The combined
observations indicate that CHL1 is endocytosed via a
clathrin-dependent pathway to be targeted to SVs in
response to synapse activation.
CHL1 Regulates Clathrin Uncoating from CCSVs
In neurons and nonneuronal cells, Hsc70 is the major
ATPase mediating clathrin uncoating from clathrin-
coated vesicles (Newmyer and Schmid, 2001). In synap-
ses, Hsc70 uncoates clathrin from SVs recycling via a cla-
thrin-dependent pathway (Zinsmaier and Bronk, 2001;
Morgan et al., 2001). We therefore investigated whether
abnormalities in subcellular distribution of Hsc70 inCHL12/2 brains may affect levels of clathrin expression.
Indeed, the intensity of clathrin labeling measured in syn-
aptophysin clusters was slightly increased in cultured
CHL12/2 versus CHL1+/+ neurons (Figure 5A). Protein
and mRNA levels of clathrin were also higher in CHL12/2
brain homogenates (Figure 5B and Figure S3) and levels
of clathrin protein were increased in CHL12/2 synapto-
somes and purified SVs (Figures 5B and 5C), suggesting
that CHL1 is important for clathrin uncoating from SVs.
To assess the role of CHL1 in clathrin release from SVs,
we isolated CCSVs from CHL1+/+ and CHL12/2 brains
(Maycox et al., 1992) and analyzed the rate of clathrin re-
lease from CCSVs in response to application of an ATP-
regenerating cocktail. The extent of CCSV uncoating was
assayed by following the transfer of the clathrin heavy
chain from the pellet to the supernatant after centrifuge
sedimentation of the vesicles (Chang et al., 2002). ATP-
regenerating cocktail induced rapid clathrin uncoating
from CHL1+/+ CCSVs, resulting in the release of 70%–
100% of clathrin within 3–15 min (Figure 6), indicating
that Hsc70, which copurifies with CHL1+/+ SVs (Figure
2A), was sufficient for clathrin release from these vesi-
cles in the presence of ATP. In contrast, clathrin release
from CHL12/2 CCSVs was severely impaired, resulting
in the release of only 10% of all clathrin after 15 min of
buffer application (Figure 6). A similarly impaired clathrin
release was also observed when CHL1+/+ CCSVs
were preincubated with recombinant CHL1-ID or
HPDpeptideCHL1, thus inducing competition between
endogenous CHL1 in SVs and recombinant CHL1-ID or
HPDpeptideCHL1 for peripheral proteins associated
with vesicles, including Hsc70 (Figure 6). In contrast,
QPDpeptideCHL1 did not affect clathrin uncoating, indi-
cating that the HPD motif is essential for CHL1-regulated
clathrin release. Preincubation of CCSVs with two other
binding partners of Hsc70, recombinant CSP (Tobaben
et al., 2001) or BAG-1 (Takayama et al., 1999), also did
not affect clathrin uncoating (Figure 6), indicating speci-
ficity for CHL1. Furthermore, when 400 nM recombinant
Hsc70 was included in the ATP-regenerating cocktail
during the CCSV uncoating reaction, the rate and extent
of clathrin release from CHL12/2 CCSVs were increased
to CHL1+/+ levels (Figure 6). The combined observations
indicate that CHL1 regulates clathrin release from
CCSVs by recruiting Hsc70 to their surface.
Activity-Induced Formation of CCSVs Is Reduced
after CHL1/Hsc70 Complex Disruption
To investigate whether abnormalities in clathrin release
affect formation of CCSVs in an activity-dependent man-
ner, we analyzed numbers of CCSVs in synapses of non-
treated versus high K+-stimulatedCHL1+/+ andCHL12/2
neurons by means of electron microscopy. The number
of CCSVs was increased in presynaptic boutons of mor-
phologically identified synapses of nontreated CHL12/2
neurons (Figure 7A), indicating that uncoating of CCSVsthe surface. Surface bound antibodies were then stripped. The surface bound antibodies are not detectable in neurons after stripping. Accumu-
lations of internalized CHL1 antibodies (intern. CHL1) overlap with SV2 positive synaptic boutons. Diagrams show mean intensity6 SEM of SV2
labeling and endocytosed CHL1 labeling in SV2 clusters. AU, arbitrary units. Levels of internalized CHL1, but not of endogenous SV2, in SV2
positive synaptic boutons are higher after high K+ stimulation, indicating that SV recycling induced by high K+ enhances CHL1 endocytosis in
synapses. Bar = 10 mm. n > 1600 synapses from 20 neurons from two coverslips analyzed in each group. *p < 0.05, t test.
(E)CHL1+/+ andCHL12/2CCSVs were probed by WB with antibodies against CHL1. Note that CHL1 is present inCHL1+/+ CCSVs. BH is shown for
comparison.
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1018formed under conditions of spontaneous activity in cul-
ture was inhibited when compared with CHL1+/+ synap-
ses. Already 10 s after application of high K+-containing
buffer (the earliest time tested), the number of CCSVs
increased in CHL1+/+ boutons, reached a peak at 30 s
after high K+ application, and slightly declined by 90 s at
the end of stimulation by high K+. Five minutes after ex-
changing the high K+ buffer to the nominal K+ buffer, the
number of CCSVs in CHL1+/+ boutons declined to the
level observed in nonstimulated neurons. In contrast,
the number of CCSVs in CHL12/2 boutons only slightly
increased in response to high K+ and remained at this
level until the end of stimulation, suggesting that inhibi-
Figure 5. CHL12/2 Synapses Contain Increased Levels of Clathrin
(A) CHL1+/+ and CHL12/2 neurons were colabeled with antibodies
against synaptophysin and clathrin (clath.). Immunofluorescence
signals were inverted to accentuate differences in immunolabeling
intensities between genotypes. Diagrams show mean intensity 6
SEM of clathrin labeling in synaptophysin clusters. AU, arbitrary
units. Levels of clathrin are increased in CHL12/2 versus CHL1+/+
synaptic boutons (arrows). Bar = 10 mm. n > 5000 synapses from 20
neurons from two coverslips analyzed in each group. *p < 0.05, t test.
(B and C) CHL1+/+ and CHL12/2 synaptosomes and brain homoge-
nates (B) and SVs IP with antibodies against synaptophysin (C)
were probed by WB with antibodies against clathrin. In (C), immuno-
precipitation with nonspecific IgG was performed for control. Dia-
grams show quantitation of blots from six experiments. Optical
density in CHL1+/+ was set to 100%. Mean values6 SEM are shown.
*p < 0.05, paired t test. Levels of clathrin are increased in CHL12/2
versus CHL1+/+ synaptosomes, brain homogenates, and SVs.tion of uncoating of CCSVs in CHL12/2 boutons ham-
pered activity-induced formation of new CCSVs. This
effect was particularly evident when activity-induced
changes in the numbers of CCSVs were compared: in
CHL1+/+ boutons, the number of CCSVs increased by a
factor of 2.6 in response to high K+, whereas in CHL12/2
neurons, this increased by only a factor of 1.6 (Figures 7A
and 7C). Inhibited formation of CCSVs was not related to
a defect in SV exocytosis, since a reduction in the total
number of SVs in response to high K+ (indicative of SVs
that had fused with the plasma membrane) was similar
in CHL1+/+ and CHL12/2 synapses (Figure 7C). Similarly,
exocytosis was normal in CHL12/2 synapses as mea-
sured by electrophysiological recordings (Nikonenko
et al., 2006). Other parameters with impact on the effi-
cacy of neurotransmission, such as number of mito-
chondria, lengths of active zones in CHL12/2 synapses,
and number of perforated synapses in CHL12/2 neurons
were also normal (Figure S4).
The relatively mild phenotype of CHL12/2 synapses at
resting conditions could be explained by compensatory
mechanisms. In particular, while mRNA and protein
levels of Hsp70, an inducible counterpart of Hsc70,
were slightly decreased in CHL12/2 brain homogenates
(Figures S2 and S3), Hsp70 protein levels were increased
by approximately 60% in CHL12/2 synaptosomes and
SVs (Figure S2), suggesting that Hsp70 is recruited to
CHL12/2 synapses instead of Hsc70, thus at least par-
tially substituting for Hsc70—a phenomenon observed
in an Hsc70-4 Drosophila mutant (Bronk et al., 2001).
To analyze the consequences of an acute CHL1/Hsc70
complex disruption, we introduced HPDpeptideCHL1
into live neurons, thus interfering with Hsc70 binding
to CHL1 in a dominant-negative fashion (Figure 1E).
Loading neurons with HPDpeptideCHL1, but not with
QPDpeptideCHL1, or mock treatment of neurons with
the peptide delivering reagent resulted in a 2-fold in-
crease in the number of CCSVs at resting conditions
and a profound reduction of CCSV formation in response
to high K+ (Figures 7B and 7C). Furthermore, in neurons
loaded with HPDpeptideCHL1, the total number of SVs
was reduced at resting conditions. The total number of
SVs in HPDpeptideCHL1-loaded synapses decreased in re-
sponse to high K+, indicating that SV exocytosis was not
blocked. However, the amplitude of this decrease was
smaller in HPDpeptideCHL1-loaded synapses when com-
pared with mock- or QPDpeptideCHL1- treated neurons.
Western blot analysis of lysates of the peptide-treated
cultures showed that the total levels of CSP and Hsp70
were not changed in HPDpeptideCHL1-loaded neurons
(Figure S5A), indicating that compensatory mechanisms
were not active at the time the cultures were analyzed.
The levels of Hsp70 and CSP were slightly decreased in
synaptophysin accumulations in neurons treated with
HPDpeptideCHL1 (FigureS5B)—aneffect that was probably
related to a reduced number of SVs in these synapses.
Changes in the numbers of CCSVs correlated with the
changes in the levels of Hsc70 and clathrin in synapto-
physin accumulations in neurons treated with high K+
(Figure 7D). In mock- or QPDpeptideCHL1-loaded neu-
rons, synaptic levels of Hsc70 and clathrin increased
30 s after application of high K+ and returned to initial
levels 5 min after a 90 s stimulation with high K+. In non-
stimulated neurons loaded with HPDpeptideCHL1, levels
CHL1 and Synaptic Vesicle Uncoating
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Isolated CCSVs were used for the in vitro clathrin uncoating assay. CCSVs before initiation of the uncoating reaction and clathrin released from
CCSVs after initiation of clathrin uncoating, collected at indicated time points (in minutes), were probed by WB with antibodies against clathrin.
Experiments were performed for CHL1+/+ and CHL12/2 CCSVs in the absence or presence of recombinant proteins or HPDpeptideCHL1 (HPD) or
QPDpeptideCHL1 (QPD) peptides as indicated. Diagrams show quantitation of the blots from six experiments with optical density for untreated
CCSVs set to 100%. Mean values6 SEM are shown. *p < 0.05, paired t test. Note the strongly reduced uncoating of clathrin fromCHL12/2CCSVs
and CHL1+/+ CCSVs preincubated with 167 nM CHL1-ID or 400 nM HPDpeptideCHL1. Efficiency of CHL1
2/2 CCSV uncoating is increased to
CHL1+/+ levels by application of 400 nM recombinant Hsc70 during the uncoating reaction. Uncoating of clathrin is not affected by 400 nM
QPDpeptideCHL1, 400 nM CSP, or 400 nM BAG-1.of clathrin were increased, whereas levels of Hsc70 were
decreased in synaptophysin clusters. The increase in
synaptic levels of clathrin and Hsc70 in response tohigh K+ in these neurons was attenuated. These obser-
vations indicate that CHL1 recruits Hsc70 to synaptic
boutons not only at resting conditions, but even more
Neuron
1020Figure 7. Activity-Induced Formation of Clathrin-Coated Synaptic Vesicles Is Inhibited in CHL12/2 Synapses and in CHL1+/+ Synapses in which
the CHL1/Hsc70 Complex Is Disrupted
(A–D) CHL1+/+ and CHL12/2 neurons (A and C) or CHL1+/+ neurons loaded with HPDpeptideCHL1 (HPD) or QPDpeptideCHL1 (QPD), or mock-
treated with the peptide delivering reagent (B–D), were incubated in modified Tyrode solution containing 4 mM K+ (control) or 47 mM K+ for
the indicated time intervals or allowed to recover for 5 min at 4 mM K+ before fixation. Neurons were fixed for electron microscopy (A–C) or im-
munofluorescence analysis (D). (A and B) Representative electron micrographs for conditions indicated in (A) (for A and B) are shown. CCSVs are
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1021efficiently after activation, allowing for dynamic changes
in clathrin levels at the synapse in response to synaptic
activity. To understand the nature of CHL1-mediated re-
cruitment of Hsc70 to activated synapses, we immuno-
precipitated CHL1 from nonstimulated or stimulated
synaptosomes. Approximately 6% and 33% of all
Hsc70 coimmunoprecipitated with CHL1 from nonstim-
ulated and stimulated synaptosomes, respectively,
suggesting a potentiated interaction between CHL1
and Hsc70 in activated synapses (Figure 7E). This effect
was reversible; levels of coimmunoprecipitated Hsc70
decreased to 13% after withdrawal of high K+.
Activity-Dependent Uptake and Release of FM Dyes
Are Reduced in Synaptic Boutons after CHL1/Hsc70
Complex Disruption
To corroborate our finding that abnormalities in clathrin
uncoating in CHL12/2 synaptic boutons affect recycling
of SVs, we analyzed the efficiency of FM dye uptake to
synaptic boutons of cultured CHL1+/+ or CHL12/2 neu-
rons in response to stimulation with high K+. Uptake of
FM4-64 applied in high K+-containing buffer for 90 s, a
protocol that labels the total pool of SVs recycling via
clathrin-dependent and -independent pathways (Virmani
et al., 2003), was only slightly decreased inCHL12/2 syn-
aptic boutons when compared with CHL1+/+ synaptic
boutons (Figure 8A). In contrast to the uptake of the
highly lipophilic FM4-64 dye, uptake of the less lipophilic
FM2-10 dye is more sensitive to the rate of endocytosis,
since this dye can be washed away more readily from
the relatively slowly forming invaginations of synaptic
plasma membranes preceding endocytosis via the cla-
thrin-dependent pathway (Richards et al., 2000; Virmani
et al., 2003). The amount of FM2-10 taken up into
CHL12/2 synaptic boutons was reduced by approxi-
mately 50% when compared with CHL1+/+ neurons
(Figure 8A). We also used a fixable analog of FM1-43—
FM1-43FX, allowing us to analyze dye uptake in relation
to the size of SV clusters visualized with SV2 antibodies
after fixation of the neurons. Whereas SV2 accumula-
tions did not differ in CHL1+/+ and CHL12/2 neurons,
levels of FM1-43FX, which is less lipophilic than FM4-
64 but more lipophilic than FM2-10, were also reduced
when measured in SV2 clusters in CHL12/2 neurons.
The changes in FM1-43FX uptake were smaller than
changes observed for FM2-10 but larger than those for
FM4-64 (Figure 8B). A similarly reduced FM1-43FX up-
take was observed in CHL1+/+ neurons loaded with
HPDpeptideCHL1 (Figure 8C). SV2 accumulations in theseneurons were also reduced, in agreement with our obser-
vation that the number of SVs in synapses is reduced
after introduction of HPDpeptideCHL1.
A reduced processing of SVs via clathrin-dependent
recycling could make them unavailable for exocytosis
in response to the next stimulus. Interestingly, in accor-
dance with this idea, when synaptic boutons in CHL1+/+
and CHL12/2 cultures were loaded with FM4-64 at high
K+, and when release of the dye from synaptic boutons
identified by FM4-64 labeling was induced by a second
pulse of high K+, the rate of FM4-64 release was signifi-
cantly reduced inCHL12/2 synaptic boutons (Figure 8D).
A similar effect was observed in CHL1+/+ neurons after
introduction of HPDpeptideCHL1 (Figure 8E). In sum-
mary, these observations suggest that reduced clathrin
uncoating from SVs slows the rate of SV recycling either
in CHL12/2 synapses or after disruption of the CHL1/
Hsc70 complex by an interfering peptide.
Discussion
We demonstrate a role for the cell adhesion molecule
CHL1 in the regulation of uncoating of CCSVs: to control
uncoating of CCSVs, CHL1 associates with the constitu-
tively expressed heat shock cognate Hsc70. Interest-
ingly, we found that high levels of Hsc70 cofractionate
with CHL1 in the synaptic membrane fraction, indicating
that Hsc70 forms a complex with CHL1 in the plasma
membrane. CHL1-mediated recruitment of Hsc70 is sig-
nificantly enhanced in the presence of ADP, whereas
CHL1/Hsc70 complex is dissociated by ATP. ATP-de-
pleting, and thus ADP-producing, reactions accompany
fusion of SVs (Sollner et al., 1993) and/or initiation of cla-
thrin coat assembly (Schmid and Smythe, 1991) and
should result in a local increase in ADP concentration
beneath the plasma membrane. It is thus tempting to
speculate that this increase in ADP concentration pro-
motes activity-dependent CHL1/Hsc70 complex forma-
tion as observed in isolated synaptosomes, thereby in-
ducing an initial CHL1-dependent recruitment of Hsc70
to the synaptic plasma membrane. Interestingly, the
Hsc70 binding partner auxilin is also initially recruited
to the growing clathrin cages and budding vesicles at
the cell surface (Massol et al., 2006). Following ATP-in-
dependent invagination of clathrin-coated pits (Mahaf-
fey et al., 1989; Smythe et al., 1989) and ATP/GTP-de-
pendent budding of the vesicles (Carter et al., 1993;
Schmid and Smythe, 1991), CCSVs translocate to the
synapse interior away from the ATP-depleted areamarked with dashed circles. Bars = 0.5 mm. (C) Diagrams show numbers of CCSVs per synaptic bouton profile, changes in the number of CCSVs
with respect to control neurons, total number of SVs, and the ratio of CCSV number to total SV number. Mean numbers 6 SEM are shown.
Note increased numbers of CCSVs in control and reduced increase in numbers of CCSVs in response to high K+ in CHL12/2 neurons and
HPDpeptideCHL1-loaded CHL1
+/+ neurons. n > 200 synapses from at least four coverslips analyzed in each group. *p < 0.05, t test. (D) Neurons
were colabeled with antibodies against synaptophysin, Hsc70, and clathrin. Levels of Hsc70 and clathrin were measured in synaptophysin ac-
cumulations. Note slightly increased levels of clathrin and reduced levels of Hsc70 in HPDpeptideCHL1-loaded neurons at resting conditions, and
reduced increase of synaptic Hsc70 and clathrin levels in these neurons in response to high K+. n > 5000 synapses from 30 neurons from three
coverslips analyzed in each group. In (C) and (D), *p < 0.05, t test indicates differences between CHL12/2 and CHL1+/+ neurons or between
HPDpeptideCHL1- and mock-loaded neurons.
#p < 0.05, t test shows statistically significant difference when neurons of the same genotype or
neurons loaded with the same peptide are compared with the control group of neurons of a particular genotype or the control group loaded
with a particular peptide. (E) CHL1 was IP from nontreated or high K+-treated synaptosomes. In the third group, high K+ was applied for 90 s
and immediately exchanged with the nominal K+. Immunoprecipitates, protein input, and material not bound to the beads were probed by
WB with antibodies against CHL1 and Hsc70. Diagram shows quantitation of coimmunoprecipitated Hsc70 levels from four experiments with
optical density for the input material set to 100%. Mean values 6 SEM are shown. *p < 0.05, paired t test. Level of coimmunoprecipitated
Hsc70 is increased in response to high K+.
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1022Figure 8. Synaptic Vesicle Recycling Is Inhibited in CHL12/2 Synap-
ses and CHL1+/+ Synapses in which the CHL1/Hsc70 Complex Is
Disrupted
(A) CHL1+/+ and CHL12/2 neurons were incubated in high K+ for 90 s
in the presence of FM4-64 or FM2-10 dyes. Diagrams show mean
values 6 SEM of FM dye intensity in FM dye cluster multiplied by
the cluster area. AU, arbitrary units. Note reduced uptake of FM2-
10 and slightly reduced uptake of FM4-64 into CHL12/2 synapses.
n > 600 synapses from 20 neurons from four coverslips analyzed
in each group. *p < 0.05, t test. Bar = 10 mm.
(B and C) CHL1+/+ and CHL12/2 neurons (B) or CHL1+/+ neurons
loaded with HPDpeptideCHL1 (HPD) or QPDpeptideCHL1 (QPD), or
mock-treated (C), were incubated in high K+ for 90 s in the presence
of FM1-43FX, fixed, and colabeled with SV2 antibodies. Diagramsbeneath the plasma membrane. This should result in an
increase in ATP concentration that would dissociate the
CHL1/Hsc70 complex and promote binding of Hsc70 to
auxilin, accompanied by ATP-dependent clathrin re-
lease.
This scenario suggests that CHL1 is endocytosed to
SVs. Indeed, we found that CHL1 is present in a highly
purified fraction of SVs and is endocytosed to synapses
in response to synapse activation. The recycling pool of
SVs in hippocampal synapses comprises only 10%–
20% of SVs, with an even smaller fraction of SVs recy-
cling via the clathrin-dependent pathway (Rizzoli and
Betz, 2005; Harata et al., 2001). Thus, only a subpopula-
tion of SVs should contain CHL1, which is targeted to
recycling SVs from the axonal plasma membrane by en-
docytosis. The intracellular domain of CHL1 contains
binding motifs for the adaptor protein AP2 that could re-
cruit CHL1 to the budding CCSVs. This adaptor protein,
which is enriched in the presynaptic membrane (Yao
et al., 2002), coordinates clathrin coat assembly and re-
cruitment of the cargo proteins to the budding clathrin-
coated vesicles (Schmid, 1997). Accordingly, we show
that CHL1 is present in CCSVs and associates with cla-
thrin. Interestingly, ADP promotes not only CHL1/Hsc70,
but also CHL1/clathrin, complex formation, indicating
that ATP-consuming, and thus ADP-producing, fusion
of SVs may promote redistribution of the CHL1/Hsc70
complex to clathrin-coated pits and budding vesicles.
The CHL1/clathrin complex dissociates in the presence
of ATP, indicating that an increase in ATP concentration
in the vicinity of the CHL1-containing CCSVs should in-
duce not only dissociation of Hsc70, but also of clathrin,
from CHL1, thus further promoting clathrin release from
the vesicle.
Levels of Hsc70 associated with SVs are strongly re-
duced in CHL12/2 mice, indicating that CHL1 not only
recruits Hsc70 to synaptic plasma membrane, but also
maintains high levels of Hsc70 associated with SVs. In-
terestingly, Hsc70 binds to CSP, another SV-associated
protein, which could provide a targeting cue for Hsc70
as well as CHL1. Although levels of Hsc70 associated
with SVs were not found to be abnormal in CSP-deficient
show mean values6 SEM of FM1-43FX or SV2 intensity in SV2 clus-
ters multiplied by the cluster area. AU, arbitrary units. Note reduced
uptake of FM1-43FX to synaptic boutons in CHL12/2 or CHL1+/+
neurons loaded with HPDpeptideCHL1. n > 2000 synapses from 30
neurons from three coverslips analyzed in each group. *p < 0.05,
t test.
(D and E) Synapses of CHL1+/+ and CHL12/2 neurons (D) or CHL1+/+
neurons loaded with HPDpeptideCHL1 (HPD) or QPDpeptideCHL1
(QPD), or mock-treated (E), were loaded with FM4-64 by incubation
in high K+ for 90 s in the presence of the dye. After washing in mod-
ified Tyrode solution containing normal levels of K+, high K+ was
again applied and FM4-64 release from the synapses was monitored
with time. The diagram shows mean values6 SEM of FM4-64 inten-
sity in FM4-64 clusters at the indicated time points after high K+
application. For each synaptic bouton, FM4-64 intensity values im-
mediately before application of high K+ were set to 1. Note reduced
rate of FM4-64 release from synaptic boutons of CHL12/2 and
HPDpeptideCHL1-loaded CHL1
+/+ neurons. Forty seconds after initi-
ation of the FM4-64 release, the difference became statistically
significant and remained statistically significant for each time point
until the end of the recordings (p < 0.05, t test, not depicted in the
figure). n > 100 synapses from five neurons from five coverslips
analyzed in each group.
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1023mice (Tobaben et al., 2001), binding of Hsc70 to CSP, the
levels of which are strongly increased in CHL12/2 SVs,
may explain the rather mild phenotype of CHL12/2
mice and residual targeting of endogenous or overex-
pressed Hsc70 to synapses in the absence of CHL1.
Reduced uptake and rate of release of FM dyes from
CHL12/2 synapses suggest that SV recycling is slowed
down in CHL12/2 mice. It is likely that reduced rate of
clathrin coat release from CCSVs results in slower pro-
cessing of SVs via the recycling pathway. In addition,
slowed recycling rates may reflect the lack of availability
of essential coat proteins to form new CCSVs in an activ-
ity-dependent manner: clathrin, AP180, and AP2 could
be trapped in CCSVs formed during previous cycles of
neuronal activity, and would thus be unavailable to
form new CCSVs. This hypothesis is supported by our
observation that, whileCHL12/2 synaptic boutons accu-
mulate abnormally high numbers of CCSVs under condi-
tions of spontaneous activity in cultured hippocampal
neurons, formation of new CCSVs in CHL12/2 synaptic
boutons in response to a new stimulus, such as high
K+ application, is inhibited.
Besides regulating uncoating of CCSVs, Hsc70 also
plays a role in SV exocytosis in cooperation with CSP
(Bronk et al., 2001). Normal SV exocytosis in CHL12/2
mice may be related to increased levels of CSP and
Hsp70, which may partially compensate for abnormal
Hsc70 function. It is interesting in this respect that
when the CHL1/Hsc70 complex is acutely disrupted in
neurons by an interfering peptide, a smaller reduction
in the number of SVs in response to high K+ is observed,
suggesting that fewer SVs fuse with the plasma
membrane.
A reduced rate of SV recycling may affect proper func-
tioning of neural circuits and information processing
in the brain, manifested by multiple abnormalities in be-
havior in CHL12/2 mice. Two independent studies have
shown a positive correlation between a missense poly-
morphism in the CHL1 gene and schizophrenia in hu-
mans (Chen et al., 2005; Sakurai et al., 2002), a finding
that can not be explained by a molecular mechanism
so far. Whereas an understanding of the many molecular
mechanisms underlying schizophrenia remains pres-
ently rudimentary, it is well established that schizophre-
nia is a complex and predominantly genetic disorder. It is
not characterized by a single causative gene; alterations
in different critical genes predispose a subject in various
ways, but in a convergent fashion, to a central patho-
physiological process: an alteration in synapse function
and an eventual disruption of neural circuits (Harrison
and Weinberger, 2005). In this respect, it is interesting
that alterations in at least one other gene, Epsin 4, encod-
ing the clathrin-associated protein enthoprotin, also
cause genetic susceptibility to schizophrenia (Pimm
et al., 2005). Furthermore, expression levels of Hsc70
were also changed in animal models of schizophrenia
(Fatemi et al., 2005), suggesting that abnormalities in
Hsc70 function and clathrin recycling pathways may
contribute to an aspect of schizophrenia etiology. Addi-
tional analyses are required to establish the mechanisms
by which mutations in CHL1, and alterations in clathrin-
dependent SV recycling, contribute to abnormalities in
information processing in the brain that eventually result
in neurological disorders.Experimental Procedures
Antibodies and Toxins
Rabbit polyclonal antibodies against the extracellular domain of
mouse CHL1 (Buhusi et al., 2003) and rat monoclonal antibody 555
against the extracellular domain of L1 (Appel et al., 1993) have
been described. Mouse monoclonal antibodies against SV2 and
the a1 subunit of Na,K-ATPase (a6F) (Developmental Studies
Hybridoma Bank, Iowa City, IA); mouse monoclonal antibodies
against the clathrin heavy chain, g-adaptin, CSP, and EEA1 (BD Bio-
sciences, San Jose, CA); goat polyclonal antibodies against synap-
tophysin, Hsp70, and Hsc70 (Santa Cruz Biotechnology, Santa Cruz,
CA); mouse monoclonal antibodies against PSD95 (Upstate Bio-
technology, Lake Placid, NY); rabbit polyclonal antibodies against
His6 tag (Cell Signaling Technology, Inc., Beverly, MA); mouse
monoclonal antibodies against MAP2; rabbit polyclonal antibodies
against actin; and nonspecific rabbit Ig (Sigma, St. Louis, MO)
were used after confirming that the antigen-specific antibodies re-
acted by western blot analysis only with bands of the correct molec-
ular weights from mouse tissue. Rabbit polyclonal antibodies
against synaptophysin and CSP were generous gifts from Reinhard
Jahn (Max-Planck-Institute for Biophysics, Go¨ttingen, Germany)
and Guido Meyer (Max-Planck-Institute for Experimental Medicine,
Go¨ttingen, Germany). Secondary antibodies against rabbit, goat,
rat, and mouse Ig coupled to horseradish peroxidase (HRP), Cy2,
Cy3, or Cy5 were from Dianova (Hamburg, Germany). DL-AP5 and
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) were purchased
from Tocris (Ballwin, MO).
Cultures and Transfection of Hippocampal
Neurons and CHO Cells
Cultures of hippocampal neurons were prepared using 1- to 3-day-
old CHL1+/+ and CHL12/2 mice (Montag-Sallaz et al., 2002) as de-
scribed (Sytnyk et al., 2002). Neurons were maintained in culture
for 12–16 days. CHO cells were maintained in Glasgow-modified
Eagle’s medium containing 10% fetal calf serum. Hippocampal neu-
rons were transfected 3 days after plating using Lipofectamine 2000
(GIBCO Invitrogen, Carlsbad, CA) according to the manufacturer’s
instructions. Peptides were introduced to neurons 12 days after plat-
ing using Chariot (Active Motif, Rixensart, Belgium) or Pulsin (Biomol,
Hamburg, Germany) according to the manufacturers’ instructions.
Both reagents provided similar results. CHO cells were transfected
using Lipofectamine with Plus reagent (GIBCO Invitrogen) following
the manufacturer’s instructions.
Immunofluorescence and FM Uptake Quantification
In fixed and permeabilized neurons, labeling with synaptophysin or
SV2 antibodies was used to identify synaptic boutons. In live neu-
rons, synaptic boutons were identified using FM dye labeling. In all
these cases, a synaptic bouton was defined as an accumulation of
the corresponding labeling with a mean intensity of at least 30%
higher than background. The background was defined as the
mean intensity of pixels in the square 30 3 30 pixel area located in
the vicinity of the synaptic bouton in the part of the image free of syn-
aptic boutons. Synaptic boutons were outlined using a threshold
function of Scion Image software (Scion Corporation, Frederick,
MD). Within the outlines, mean intensities of the labeling with the an-
tibodies indicated in the text or with FM dyes were measured and
expressed in arbitrary units, defined as 8 bit pixel values of the gray-
scale image. In each experiment, images were acquired using iden-
tical settings and the same threshold was used for all groups. All
experiments were performed 3–4 times with the same effect.
Clathrin Uncoating Assay
A suspension of CCSVs (25 ml) was mixed with 20 mM HEPES (pH
7.0), containing 25 mM KCl, 2 mM MgCl2, 10 mM (NH4)2SO4, 2 mM
ATP, 5 mM phosphocreatine, and 5 units/ml creatine phosphokinase
(Sigma) on ice. High concentrations of free K+ ions in the uncoating
buffer are required to stimulate uncoating activity of Hsc70 (Palleros
et al., 1993). Samples were then incubated for 1, 3, 6, 9, 12, or 15 min
at 25C to induce clathrin uncoating. Samples were then placed on
ice to stop the reaction and centrifuged at 100,000 3 g for 15 min
at 4C. Supernatants containing clathrin released from the CCSVs
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blot analysis.
Coimmunoprecipitation
Homogenates from adult mouse brains were prepared in 50 mM
Tris-HCl buffer (pH 7.5) containing 1 mM of CaCl2, 1 mM MgCl2,
and 1 mM NaHCO3. Samples containing 1 mg of total protein were
lysed for 40 min at +4C with lysis buffer (pH 7.5) containing 50
mM TrisHCl, 150 mM NaCl, 1% Nonidet P-40, 1 mM Na2P2O7, 1 mM
NaF, 1 mM EDTA, 2 mM NaVO4, 0.1 mM PMSF, and complete prote-
ase inhibitor cocktail (Roche Diagnostics), and centrifuged for 15
min at 20,000 3 g at 4C. Supernatants were cleared with protein
A/G-agarose beads (Santa Cruz Biotechnology) (3 hr at 4C) and in-
cubated with corresponding antibodies or nonspecific control Ig
(overnight, 4C), followed by precipitation with protein A/G-agarose
beads (1 hr, 4C). The beads were washed three times with lysis
buffer and two times with PBS. To quantify levels of coimmunopre-
cipitated complexes, proteins in the same amount of starting mate-
rial as used for coimmunoprecipitation, and proteins in the material
that did not bind to the beads during coimmunoprecipitation, were
precipitated by TCA (12.5% final concentration). Beads and precip-
itated proteins were boiled in the same volumes of Laemmli buffer
and used for western blot analysis. Equal volumes of the samples
were applied to the gels.
Supplemental Data
The Supplemental Data for this article contain details on 2D gel
electrophoresis and overlay assay; DNA constructs; indirect immu-
nofluorescence staining; analysis of CHL1 antibody uptake; loading
and unloading of FM dyes; preparation of brain tissue homoge-
nates and isolation of synaptosomes, SVs, and CCSVs; analysis
of Hsc70 binding to synaptic membranes; western blot analysis;
electron microscopy; and quantitative real-time PCR. They can
be found online at http://www.neuron.org/cgi/content/full/52/6/
1011/DC1/.
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